Prohealbiologix
Latest round
- Angel
Last raised
- Jan 2020
Total raised
- Undisclosed
Investors
- 1
About Prohealbiologix
Founded in 2019 and based in Suzhou, China, Prohealbiologix operates as a biopharmaceutical company that focuses on the production and sales of biomolecule drugs. Its team members come from pharmaceutical companies such as Allergan, Pfizer, and Johnson & Johnson. In August 2020, the company opened its R&D center in the Biomedical Industrial Park. Its IGF1-R antibody, PHP1003, received a clinical trial application in April 2022 from the NMPA (National Medical Products Administration). Prohealbiologix's main business is the research, development, production, and sales of innovative drugs in therapeutic areas such as ophthalmic diseases, immune diseases, and tumors. Its ophthalmic product lines include PHP1003 injection and PHP0101 eye drops, etc. The PHP1003 injection has entered Phase II clinical trials, which adopt the administered methods by subcutaneous injection. Products can be used in the treatment of presbyopia, retinopathy, and immune disorders. The company generates revenue by providing biomolecule drugs in therapeutic areas. The company will use the strategic investment for the development of the ophthalmic clinical drug pipeline.
Who invested in Prohealbiologix
1 investor across 1 round
See all investors in Prohealbiologix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jan 22, 2020
Amount
Undisclosed
Investors
Questions about Prohealbiologix
Who invested in Prohealbiologix?
Prohealbiologix has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prohealbiologix raised?
Prohealbiologix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Prohealbiologix last raise money?
Prohealbiologix's most recent round on record is a Angel, in Jan 2020.
What does Prohealbiologix do?
Founded in 2019 and based in Suzhou, China, Prohealbiologix operates as a biopharmaceutical company that focuses on the production and sales of biomolecule drugs.
Where is Prohealbiologix headquartered?
Prohealbiologix is headquartered in Suzhou, China.
Which VCs invest in companies like Prohealbiologix?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Prohealbiologix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like Prohealbiologix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.